Jan 14, 2021
Read Geekwire article: Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases
Sep 20, 2020
Chad is the co-founder and CEO of Adaptive Biotechnologies, a commercial-stage biotech company in Seattle that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease.
Sep 15, 2020
AltPep completes round of initial seed funding.
Sep 15, 2019
Apr 17, 2019
Apr 16, 2019
View article here.
Apr 16, 2019
Apr 16, 2019
View article here.
Apr 15, 2019
View article here.
Apr 15, 2019
View fact sheet here.
Recent Comments